ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus

NCT02910089 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1400
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca

Collaborators